跳至主要内容
临床试验/CTRI/2024/11/076607
CTRI/2024/11/076607尚未招募3 期

Comparative Assessment of Efficacy of Vitamin B12 spray versus Benzydamine Hydrochloride spray in Prevention and Management of Radiation Mucositis-A Randomized Clinical Trial

Mandapati Harshitha1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2024年11月28日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
28
试验地点
1
主要终点
Pain score using visual analog scale every week for 8 weeks

研究概览

简要总结

MY AIM OF THE STUDY IS TO EVALUATE THE EFFICACY OF VITAMIN B12 ORAL SPRAY  COMPARED TO BENZYDAMINE HYDROCHLORIDE SPRAY

Ø  Sample size was estimated using g power analysis with effect size of 1.1, alpha error of 0.05 and 80 power total sample size achieved was 28 i.e. 14 patients per each group.

Ø  A total number of 28 patients who will be undergoing radiotherapy will be randomly assigned into 2 groups i.e. GROUP A and GROUP B by simple random sampling using lottery method.

Ø  Group A (STUDY GROUP) will be given vitamin B12 oral spray four times a day before the start of radiation therapy till 2 weeks after the radiation therapy.

Ø  Group B (CONTROL GROUP) will be given benzydamine hydrochloride spray four times a day before the start of radiation therapy till 2 weeks after the radiation therapy.

Ø  Patients in both the groups will be instructed to use the spray as advised to them i.e. four times a day for eight weeks after taking food.

Ø  Follow up will be done every week to check for occurrence, progression and regression of oral mucositis symptoms are analysed and recorded using WHO oral mucositis assessment scale and visual analogue scale.

Ø  The follow up assessment includes observation of mucosal changes and changes in pain sensations before and after the start of treatment and the time taken for remission of inflammation in oral mucosa

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • PATIENTS WILLING TO PARTICIPATE IN THE STUDY PATIENTS WITH HEAD AND NECK CANCER WHO ARE PLANNED FOR RADIOTHERAPY.

排除标准

  • Patients who are not willing for the study Patients who are on ryles tube Patients who are on respiratory support.

结局指标

主要结局

Pain score using visual analog scale every week for 8 weeks

时间窗: Pain score using visual analog scale every week for 8 weeks | Erythema using WHO assessment scale every week for 8 weeks

Erythema using WHO assessment scale every week for 8 weeks

时间窗: Pain score using visual analog scale every week for 8 weeks | Erythema using WHO assessment scale every week for 8 weeks

次要结局

  • TO KNOW THE EFFICACY OF VITAMIN B12 SPRAY(GIVEN FOR 8 WEEKS)

研究者

发起方
Mandapati Harshitha
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Mandapati Harshitha

Narayana Dental College and Hospital

研究点 (1)

Loading locations...

相似试验